Abstract
The ability to measure estrogen metabolites (EMs) quantitatively is important for investigating their individual roles in cancer screening, treatment and prevention, as well as in a host of other hormone-related disorders. In this protocol we describe a method that is capable of quantitating 15 distinct EMs in urine. Endogenous EMs are quantitatively measured using a liquid chromatography–tandem mass spectrometry method in which the spectrometer operates in a selected reaction monitoring mode. This method is capable of quantifying estrone and its 2-, and 4- and 16α-hydroxy and its 2-, 4-methoxy derivatives, and 2-hydroxyestrone-3-methyl ether; 17β-estradiol and its 2-hydroxy, and 2- and 4-methoxy derivates, and estriol, 16-epiestriol, 17-epiestriol, and 16-ketoestradiol. The method requires only 0.5 ml of urine and approximately 60 urine samples can be quantitatively analyzed per week.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Yager, J.D. & Davidson, N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270–282 (2006).
Clemons, M. & Goss, P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 344, 276–285 (2001).
Fishman, J. et al. Increased estrogen-16 α-hydroxylase activity in women with breast and endometrial cancer. J. Steroid Biochem. 20, 1077–1081 (1984).
Helguero, L.A., Faulds, M.H., Gustafsson, J.A. & Haldosen, L.A. Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24, 6605–6616 (2005).
Zhu, B.T., Han, G.Z., Shim, J.Y., Wen, Y. & Jiang, X.R. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: Insights into the structural determinants favoring a differential subtype binding. Endocrinology 147, 4132–4150 (2006).
Cavalieri, E.L. et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94, 10937–10942 (1997).
Lakhani, N.J., Sarkar, M.A., Venitz, J. & Figg, W.D. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165–172 (2003).
Ball, P., Reu, G., Schwab, J. & Knuppen, R. Radioimmunoassay of 2-hydroxyestrone and 2-methoxyestrone in human urine. Steroids 33, 563–576 (1979).
Emons, G., Mente, C., Knuppen, R. & Ball, P. Radioimmunoassay for 4-hydroxyoestrone in human urine. Acta Endocrinol. (Copenh). 97, 251–257 (1981).
Ziegler, R.G et al. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestrone in urine. Environ. Health Perspect. 105, 607–614 (1997).
Suzuki, E., Saegusa, K., Matsuki, Y. & Nambara, T. Assay of enzymic O-methylation of catechol estrogens by high-performance liquid chromatography with coulometric detection. J. Chromatogr. 617, 221–225 (1993).
Adlercreutz, H., Kiuru, P., Rasku, S., Wahala, K. & Fotsis, T. An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine. J. Steroid Biochem. Mol. Biol. 92, 399–411 (2004).
Xu, X. et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal. Chem. 77, 6646–6654 (2005).
Todorovic, R. et al. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis 22, 905–911 (2001).
Shimada, K., Xie, F.M., Niwa, T., Wakasawa, T. & Nambara, T. Studies on steroids. CCXXIX. Separation and characterization of catechol oestrogen glucoronides in urine of pregnant women by high-performance liquid chromatography. J. Chromatogr. 400, 215–221 (1987).
Adlercreutz, H. et al. Estrogen metabolism and excretion in Oriental and Caucasian women. J. Natl. Cancer Inst. 86, 1076–1082 (1994).
Xu, X., Duncan, A.M., Merz-Demlow, B.E., Phipps, W.R. & Kurzer, M.S. Menstrual cycle effects on urinary estrogen metabolites. J. Clin. Endocrinol. Metab. 84, 3914–3918 (1999).
Nelson, R.E., Grebe, S.K., Okane, D.J. & Singh, R.J. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin. Chem. 50, 373–384 (2004).
Tai, S.C. & Welch, M.J. Development and evaluation of a reference measurement procedure for the determination of estradiol-17β in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal. Chem. 77, 6359–6363 (2005).
Frei-Häusler, M. & Frei, R.W. An investigation of fluorigenic labelling of chlorophenols with dansyl chloride. J. Chromatogr. 84, 214–217 (1973).
Quirke, J.M.E., Adams, C.L. & Van Berkel, G.J. Chemical derivatization for electrospray ionization mass spectrometry. 1. Alkyl halides, alcohols, phenols, thiols, and amines. Anal. Chem. 66, 1302–1315 (1994).
Anari, M.R et al. Derivatization of ethinylestradiol with dansyl chloride to enhance electrospray ionization: application in trace analysis of ethinylestradiol in rhesus monkey plasma. Anal Chem. 74, 4136–4144 (2002).
Xu, X. et al. Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry. Anal Chem. 78, 1553–1558 (2006).
Acknowledgements
This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under Contract NO1-CO-12400 and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the United States Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Xu, X., Keefer, L., Ziegler, R. et al. A liquid chromatography–mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc 2, 1350–1355 (2007). https://doi.org/10.1038/nprot.2007.176
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.176
This article is cited by
-
Markers of Local and Systemic Estrogen Metabolism in Endometriosis
Reproductive Sciences (2021)
-
The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
Hormones (2020)
-
Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status
Cancer Causes & Control (2019)
-
Liquid chromatography–time-of-flight high-resolution mass spectrometry study and determination of the dansylated products of estrogens and their hydroxylated metabolites in water and wastewater
Analytical and Bioanalytical Chemistry (2018)
-
CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites
British Journal of Cancer (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.